DUX4 and facioscapulohumeral muscular dystrophy: In the work of Himeda et al., the authors showed that targeting either the promoter or the first exon of DUX4 by dSaCas9 fused with epigenetic repressors significantly reduced the expression level of DUX4 in myocytes from biopsies of FSHD patients [72].